Morten Ruhwald

Morten Ruhwald

Director, Tuberculosis Programme

Location Geneva, Switzerland

About Morten Ruhwald

Morten joined FIND in 2019 and leads the TB programme. In this role, Morten is responsible for a large portfolio of partnerships, development projects and clinical trials spanning biomarkers, next generation LAM assays, molecular assays for TB and drug resistance detection, digital diagnostics and AI based tools. Priorities for the programme are to develop, trial and support implementation of new non-sputum based tests and sampling strategies for primary health care, new tools to detect drug resistance and new screening tests.

Prior to joining FIND, Morten was Chief Medical Officer at Statens Serum Institut in Copenhagen, Denmark where he oversaw the clinical development of the TB and Chlamydia vaccine programs, and the TB diagnostic program.

Morten is a Medical Doctor and holds a PhD in TB immunology from Copenhagen University.